CCL2 and plasma cell myeloma: In multiple myeloma patients, for example, transendothelial migration through the bone marrow endothelial cell monolayer is accelerated by the autocrine action of monocyte chemoattract protein-1 (MCP-1) following activated TNFR2 signaling (Figure 2) [54].